Their experimental work showed synthetic cannabinoids not only reduce tumour cells but that p53 could also act as an activator or inhibitor of autophagy and apoptosis and this depends on subcellular localisation and the mutant variant of p53 (Ellert-Miklaszewska et al. 2021). The gene discussed is TP53; the disease is neoplasm.